NCT06525961View on ClinicalTrials.gov

iTear Single-center, Open-label, Single-arm Study

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

January 31, 2026

Conditions
Dry Eye DiseaseDry Eye SyndromesDry EyeMeibomian Gland Dysfunction
Interventions
DEVICE

iTEAR100 Neurostimulator

To apply an iTEAR100 Neurostimulator for the stimulation to the anterior ethmoidal nerve - which is located at the point between bony and fleshy tissue alongside the nose. Participants should apply stimulation to each side of the nose for 30 seconds, twice a day. It is recommended to apply once in the morning and once in the evening.

Trial Locations (1)

Unknown

Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

ARCTIC VISION HONG KONG BIOTECH LIMITED

UNKNOWN

lead

The University of Hong Kong

OTHER

NCT06525961 - iTear Single-center, Open-label, Single-arm Study | Biotech Hunter | Biotech Hunter